Patents by Inventor Roberto Assereto

Roberto Assereto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy of erdosteine and beta-2 agonists for treating respiratory pathologies characterized by non reversible or partially reversible airway obstruction
    Publication number: 20080033010
    Abstract: The invention relates to a method for improving the reversibility of bronchial obstruction in a subject affected by chronic obstructive pulmonary disease comprising the administration to said subject of erdosteine in combination with a beta agonist.
    Type: Application
    Filed: April 24, 2007
    Publication date: February 7, 2008
    Inventors: Mario Arbasino, Roberto Assereto
  • Pharmaceutical compositions having antineoplastic activity
    Patent number: 4871528
    Abstract: Pharmaceutical compositions containing unit or separate dosages of 2.5 to 5 grams of reduced glutathione (GSH) and known anti-tumor agents, to be used simultaneously, separately or sequentially in anti-tumor therapy.Compounds of the invention, that can be used both in mono- or polychemotherapy, reach surprising results against tumors, thus avoiding the onset of dangerous side-effects, such as nephrotoxicity induced by cisplatinum, and increasing the long term survival rates.
    Type: Grant
    Filed: October 7, 1987
    Date of Patent: October 3, 1989
    Assignee: Boehringer Biochemia Robin SpA
    Inventors: Sergio Tognella, Michele Tedeschi, Roberto Assereto, Odoardo Tofanetti, Ennio Cavalletti